ABL Bio (298380)
에이비엘바이오 KOSDAQ GLOBAL 기초 의약물질 제조업
Close (Aug 19, 2026)
₩84,100
-3.11%
Market cap
₩5T ($3.3B)
52-week range
₩59,800 –
₩257,500
P/E · P/B · Div yield
– · 29.96 ·
0%
View chart data as a table
| Date | Close | Foreign net | Institutions | Retail |
|---|---|---|---|---|
| 2026-08-14 | ₩84,100 | +₩1.2bn | ₩-8.8bn | +₩7.3bn |
| 2026-08-13 | ₩86,800 | +₩3.4bn | ₩-6.1bn | +₩2.4bn |
| 2026-08-12 | ₩86,800 | +₩0.1bn | ₩-4.5bn | +₩4.0bn |
| 2026-08-11 | ₩89,100 | ₩-9.7bn | ₩-3.4bn | +₩13.4bn |
| 2026-08-10 | ₩93,600 | ₩-23.2bn | +₩19.9bn | +₩2.5bn |
| 2026-08-07 | ₩86,600 | ₩-4.6bn | +₩3.8bn | +₩0.5bn |
| 2026-08-06 | ₩83,300 | ₩-10.0bn | +₩9.2bn | +₩1.0bn |
| 2026-08-05 | ₩80,200 | ₩-4.0bn | ₩-0.7bn | +₩4.5bn |
| 2026-08-04 | ₩80,400 | ₩-11.2bn | +₩17.1bn | ₩-6.1bn |
| 2026-08-03 | ₩71,000 | ₩-0.2bn | +₩1.5bn | ₩-1.4bn |
| 2026-07-31 | ₩66,800 | +₩5.4bn | +₩2.7bn | ₩-8.2bn |
| 2026-07-30 | ₩60,800 | +₩6.5bn | ₩-1.1bn | ₩-5.4bn |
| 2026-07-29 | ₩63,300 | +₩10.5bn | +₩4.9bn | ₩-15.4bn |
| 2026-07-28 | ₩68,800 | +₩0.3bn | +₩7.2bn | ₩-7.3bn |
| 2026-07-27 | ₩72,600 | ₩-2.5bn | +₩3.9bn | ₩-1.4bn |
| 2026-07-24 | ₩72,400 | +₩0.1bn | +₩0.1bn | ₩-0.1bn |
| 2026-07-23 | ₩74,300 | +₩3.4bn | +₩3.8bn | ₩-7.3bn |
| 2026-07-22 | ₩69,400 | +₩8.6bn | ₩-8.3bn | ₩-0.5bn |
| 2026-07-21 | ₩69,300 | +₩7.6bn | ₩-7.3bn | ₩-0.0bn |
| 2026-07-20 | ₩70,200 | +₩5.4bn | ₩-3.2bn | ₩-2.1bn |
| 2026-07-16 | ₩75,600 | +₩3.5bn | ₩-3.5bn | +₩0.5bn |
| 2026-07-15 | ₩79,300 | +₩7.9bn | +₩0.2bn | ₩-8.1bn |
| 2026-07-14 | ₩74,400 | +₩10.4bn | ₩-4.3bn | ₩-5.8bn |
| 2026-07-13 | ₩79,100 | +₩1.6bn | +₩4.2bn | ₩-5.2bn |
| 2026-07-10 | ₩81,800 | +₩7.2bn | +₩2.8bn | ₩-9.9bn |
| 2026-07-09 | ₩80,500 | +₩8.8bn | ₩-0.3bn | ₩-8.3bn |
| 2026-07-08 | ₩81,500 | ₩-7.2bn | ₩-8.4bn | +₩16.3bn |
| 2026-07-07 | ₩93,900 | +₩12.3bn | +₩4.6bn | ₩-16.6bn |
| 2026-07-06 | ₩90,200 | ₩-3.3bn | ₩-2.7bn | +₩6.1bn |
| 2026-07-03 | ₩96,100 | +₩0.0bn | +₩1.0bn | ₩-1.2bn |
| 2026-07-02 | ₩97,000 | ₩-16.2bn | +₩5.8bn | +₩11.8bn |
| 2026-07-01 | ₩101,500 | ₩-12.1bn | +₩5.9bn | +₩4.3bn |
| 2026-06-30 | ₩99,500 | ₩-12.0bn | +₩4.8bn | +₩7.1bn |
| 2026-06-29 | ₩106,600 | +₩4.7bn | +₩35.1bn | ₩-38.7bn |
| 2026-06-26 | ₩88,700 | ₩-10.2bn | +₩6.6bn | +₩3.9bn |
| 2026-06-25 | ₩95,000 | ₩-0.6bn | ₩-2.0bn | +₩2.8bn |
| 2026-06-24 | ₩98,800 | +₩6.7bn | +₩5.3bn | ₩-13.6bn |
| 2026-06-23 | ₩92,100 | +₩3.6bn | +₩8.7bn | ₩-11.9bn |
| 2026-06-22 | ₩97,700 | +₩1.8bn | +₩0.4bn | ₩-1.9bn |
| 2026-06-19 | ₩99,100 | +₩4.2bn | ₩-1.1bn | ₩-2.4bn |
| 2026-06-18 | ₩101,300 | ₩-16.8bn | ₩-3.5bn | +₩20.3bn |
| 2026-06-17 | ₩108,300 | ₩-22.5bn | +₩12.4bn | +₩8.6bn |
| 2026-06-16 | ₩98,700 | ₩-1.9bn | ₩-1.9bn | +₩3.3bn |
| 2026-06-15 | ₩95,900 | +₩4.6bn | ₩-0.1bn | ₩-5.2bn |
| 2026-06-12 | ₩91,100 | +₩1.1bn | ₩-8.6bn | +₩7.4bn |
| 2026-06-11 | ₩93,100 | +₩5.5bn | ₩-4.9bn | ₩-1.5bn |
| 2026-06-10 | ₩90,200 | +₩3.5bn | ₩-0.3bn | ₩-1.6bn |
| 2026-06-09 | ₩92,400 | +₩8.3bn | +₩0.8bn | ₩-10.6bn |
| 2026-06-08 | ₩88,600 | +₩12.7bn | ₩-0.5bn | ₩-10.8bn |
| 2026-06-05 | ₩99,800 | +₩5.7bn | ₩-1.3bn | ₩-2.7bn |
| 2026-06-04 | ₩106,000 | ₩-1.2bn | +₩2.3bn | ₩-1.3bn |
| 2026-06-02 | ₩107,100 | +₩4.1bn | +₩4.7bn | ₩-8.1bn |
| 2026-06-01 | ₩111,900 | +₩4.9bn | +₩5.5bn | ₩-9.6bn |
| 2026-05-29 | ₩111,900 | +₩7.1bn | +₩4.8bn | ₩-11.7bn |
| 2026-05-28 | ₩114,500 | +₩6.3bn | ₩-7.1bn | +₩1.4bn |
| 2026-05-27 | ₩118,500 | ₩-3.4bn | +₩1.6bn | +₩0.2bn |
| 2026-05-26 | ₩117,500 | ₩-28.9bn | +₩3.5bn | +₩26.3bn |
| 2026-05-22 | ₩120,200 | +₩5.3bn | +₩10.4bn | ₩-16.0bn |
| 2026-05-21 | ₩109,900 | +₩8.2bn | +₩1.2bn | ₩-10.0bn |
| 2026-05-20 | ₩106,300 | +₩18.1bn | ₩-5.1bn | ₩-12.0bn |
| 2026-05-19 | ₩112,000 | +₩21.2bn | ₩-2.9bn | ₩-18.2bn |
Investor flows summary
| Window | Foreign | (USD) | Institutions | Retail |
|---|---|---|---|---|
| 1 day | +₩1.2bn | +$1M | ₩-8.8bn | +₩7.3bn |
| 5 days | ₩-28.3bn | $-20M | ₩-2.9bn | +₩29.6bn |
| 20 days | ₩-12.9bn | $-9M | +₩30.8bn | ₩-19.6bn |
Positive = net buying, negative = net selling. Values aggregate the KRX main board and the NXT alternative venue.
Annual financials
| Fiscal year | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| 2023 | ₩66bn ($46M) | – | -₩3bn (-$2M) | -₩3bn (-$2M) |
| 2024 | ₩33bn ($24M) | -49.00% | -₩59bn (-$42M) | -₩56bn (-$39M) |
| 2025 | ₩79bn ($56M) | +137.60% | -₩40bn (-$29M) | -₩38bn (-$27M) |
Consolidated (K-IFRS) where available, from DART regulatory filings. USD figures converted at the current rate (₩1410.07/$) for reference only.